Medgenics (MDGN) Narrows Q3 Loss

Medgenics (NYSE: MDGN) reported Q3 EPS of ($0.21), versus ($0.33) reported last year.

For earnings history and earnings-related data on Medgenics (MDGN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• CIGNA (CI) PT Raised to $370 at Piper Sandler
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'